BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T113000
DTSTAMP:20260422T030733
CREATED:20200327T100140Z
LAST-MODIFIED:20200327T100140Z
UID:18108-1601546400-1601551800@staging.medilinkmidlands.com
SUMMARY:Webinar: Commercial Applications for Next Generation Biomaterials
DESCRIPTION:This webinar with the University of Nottingham will look at Commercial Applications for Next Generation Biomaterials. \nThe biomaterials discovery programme at the University of Nottingham has been targeting novel polymers with application as coatings for existing medical devices to reduce infection rates and controlling foreign body reaction\, cell culture consumables for expansion and differentiation of stem cells\, particulates for targeting therapeutic delivery for cancer and infections and surfaces to control viral\, fungal and bacterial attachment in a wide variety of industries. They are looking for industrial organisations to partner with in the exploitation of these materials. \nPresentations will include: \n– Controlling bacterial biofilms formation using polymers \n– Controlling foreign body reaction to medical implants using coatings \n– New materials for breast cancer therapies \n– Technologies to control Fibrosis \nThere will be a Q&A session during the webinar. We have also created a facility post event (11.30am – 12.00pm) for you to join the presenters in a Microsoft Teams meeting to ask further questions directly to the presenters. Details of this meeting will be shared during the webinar. \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nThe Biomaterials Discovery project at the University of Nottingham has funding available to partner with industrial partners that are keen to explore its emerging novel biomaterials and their potential in healthcare in short proof of concept studies. They encourage any companies that can see application of these technologies in their area to contact the panellists in the discussion session or send us an email. Please click here to contact the team. \n  \nSPEAKER PROFILES: \n \nProfessor Morgan Alexander\, Professor of Biomedical Surfaces\, University of Nottingham \nMorgan Alexander is Professor of Biomedical Surfaces\, the Director of the EPSRC Programme Grant in Next Generation Biomaterials Discovery and a Wellcome Trust Senior Investigator based in the School of Pharmacy at the University of Nottingham. He received his BSc in Materials (1988) and his PhD from the same department at The University of Sheffield in 1992. \nHis work involves developing materials for application in human healthcare and characterising relationships between surface structure and biological properties. Understanding these relationships is critical to the development of next generation biomaterials and it is the theme running through his group’s work across a variety of areas spanning control of bacterial adhesion\, to engineering cell response with applications in medical devices and cell manufacture. \n \nKiril Kalenderski\, PhD Student\, University of Nottingham \nKiril is a researcher at the University of Nottingham\, studying biofilm formation on bio-material surfaces developed as medical device coatings. He has predominantly worked with indwelling urinary catheters\, to determine the efficacy of bio-material coatings in reducing biofilm formation on these devices\, within in vitro experiments and clinical settings. \n  \n  \nDr Robert Cavanagh\, Research Fellow\, University of Nottingham \nRob completed his PhD in Drug delivery in 2017 at the University of Nottingham and focused on investigating intestinal permeability enhancers for the delivery of biologics. He joined Professor Cameron Alexander’s group in December 2017 as a post-doctoral researcher studying chemotherapeutic delivery using novel polymeric nanoparticles. \n  \n  \nDr Patrícia Monteiro\, Research Fellow\, University of Nottingham \nPatrícia received a B.Sc. and M.Sc. in Pharmacy and Pharmaceutical Sciences from the Federal University of Ouro Preto (UFOP)\, Brazil. In 2019 she completed her Ph.D. in drug delivery at the University of Nottingham. She then joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher. Her current research is focused on the development of bioresponsive polymers for triple negative breast cancer therapy. \n  \n  \n  \nDr Leanne Fisher\, Research Fellow\, University of Nottingham \nSchool of Life Sciences\, Immunology and Immuno-bioengineering Group \nLeanne’s research has focussed on the design and development of antimicrobial/anti-fouling surfaces to prevent the formation of biofilms on medical devices. More recently\, she has been studying the impact of surface engineering on immune modulation and prevention of the foreign body response. Alongside this\, Leanne works in developing immune-competent biomimetic tissue models\, specifically organ-on-a-chip models. \n  \n \nDr Matthew Vassey\, Research Fellow\, University of Nottingham \nMatthew received a B.Sc. in Microbiology and Cellular Biology in 2005 at the University of Nottingham. In 2014 he completed his Ph.D. in Cellular Microbiology also at the University of Nottingham. He joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher in November 2017. His current research is focused on cell biology\, human iPSC derived cells\, 3D biology\, host-pathogen interactions and infection biology. \n  \n  \n \nArsalan Latif\, PhD Student\, University of Nottingham \nArsalan is a final year doctoral student researching in developing stromal instructive niches to promote healing and suppress fibrosis\, at the University of Nottingham. Before which he did his master’s in biomedical engineering at Chalmers University of Technology\, Sweden. Besides science\, he enjoys building Lego models in his spare time. \n 
URL:https://staging.medilinkmidlands.com/event/commercial-applications-for-next-generation-biomaterials/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Morgan-Alexander.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201008T103000
DTEND;TZID=Europe/London:20201008T113000
DTSTAMP:20260422T030733
CREATED:20200921T111505Z
LAST-MODIFIED:20200921T111505Z
UID:18368-1602153000-1602156600@staging.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:Join EMAHSN for a virtual coffee break on Thursday 8 October at 10.30am. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis still restricts face to face events\, this online opportunity enables the life sciences community to still connect with one another. In this informal gathering\, hosted by Nick Brown\, Commercial Manager at EMAHSN\, you will have the opportunity to share your current challenges and experiences and find out how the EMAHSN can help. \nThe theme for this virtual coffee break will be Patient Public Involvement (PPI)\, Shahnaz Aziz\, PPI and Inclusion Lead from the EMAHSN will be attending to explain the importance of PPI\, how do do it well and the offers the AHSN have to support companies in this activity.  \nGrab a coffee\, a biscuit and join us. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \nChair and Panel details: \n Nick Brown\, Commercial Manager\, EMAHSN \n  \n  \n  \n  \nShahnaz Aziz\, PPI and Inclusion Lead\, EMAHSN \n  \n  \n  \n  \n Aisha Ajij\, Project Support and Industry Liaison Officer\, EMAHSN
URL:https://staging.medilinkmidlands.com/event/11088/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Shahnaz-Aziz.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201014T100000
DTEND;TZID=Europe/London:20201014T113000
DTSTAMP:20260422T030733
CREATED:20200213T124632Z
LAST-MODIFIED:20200213T124632Z
UID:18069-1602669600-1602675000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Additive Manufacturing & 3D Printing Special Interest Group (SIG)
DESCRIPTION:The Additive Manufacturing & 3D Printing Special Interest Group (SIG) is back and we have a great online event lined up for you on “Where are we now?”. \nThis event is in partnership with The University of Nottingham – Centre for Additive Manufacturing. The webinar will cover: \n– “Where are we now?”\n– The national additive manufacturing strategy: unleashing the potential in the medtech sector\n– Regulatory considerations for Additive Manufactured Medical Devices \nDURATION: 1.5 hours \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles \n\nRuth Goodridge\, Professor in Additive Manufacturing (3D Printing)\, The University of Nottingham \nRuth is Professor of Additive Manufacturing (3D-Printing) at the University of Nottingham. She is currently on secondment to Nottingham University Hospitals NHS Trust\, based in Clinical Engineering. With a degree in Biomaterials and PhD in Bioengineering\, she has a particular interest in the medical applications of Additive Manufacturing\, including assistive and rehabilitation devices (inc. prosthetics)\, implants and diagnostics. She has 20 years experience in multidisciplinary research into Additive Manufacturing\, including a 2-year JSPS fellowship held at NAIST\, Japan. Her expertise lies in material development for AM and advancing understanding of coupled material-processing aspects\, in particular for polymer and glass powder bed fusion. \n\nPaul Unwin\, Industrial Chair\, Additive Manufacturing Strategy Steering Group (AM UK) \nAM UK is an independent\, government-backed collaboration\, positioned to help drive the UK’s AM strategy. The national strategy published in September 2017 provides recommendations to enable UK industry to unlock the full commercial potential of additive manufacturing and presents the output of 5 years of work undertaken by the UK AM community.\nPreviously\, Paul was the founding CEO of the Stanmore Implants Worldwide Ltd\, who are a world renowned specialist orthopaedic implant service provider. Paul was the creator and architect of a ground-breaking patient-specific implant system that integrated patient imaging\, implant design\, implant manufacture utilising Additive Manufacturing and placing the implants with the aid of robotics\, culminating in the successful surgical placement – a world first. Paul and his team began investigating additive manufacturing for orthopaedic implants in 2006 and after following an extensive development programme built and implanted one of the first additive manufactured mega bone replacements in 2011. \n\nAshley Stratton-Powell\, Senior Medical Device Specialist\, MHRA\nAshley is Technical Lead for Orthopaedics at Medicines and Healthcare products Regulatory Agency (MHRA). He leads a team of Medical Device Specialists who are responsible for investigating trends in adverse incident reports\, issuing patient safety alerts and producing guidance on regulatory issues. He has a PhD in Medical Engineering from the University of Leeds and is a Chartered Engineer with the Institution of Mechanical Engineers.
URL:https://staging.medilinkmidlands.com/event/additive-manufacturing-3d-printing-special-interest-group-sig/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Ruth-Goodridge.jpeg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201020T140000
DTEND;TZID=Europe/London:20201020T150000
DTSTAMP:20260422T030733
CREATED:20200930T073818Z
LAST-MODIFIED:20200930T073818Z
UID:18380-1603202400-1603206000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Supply Chain - improving resilience and agility for challenging times
DESCRIPTION:This webinar alongside Mills & Reeve will consider how supply chains are evolving and adapting in these difficult times\, and what you can do to improve your crisis-resilience. \nFor all businesses\, the challenges of the COVID-19 crisis and the forthcoming end of the Brexit transition period present particular difficulties. For life sciences business\, an additional set of considerations arise. With multinational clinical studies\, complex global supply chains and multi-component products a well-planned approach is essential. The COVID-19 pandemic has brought these issues into sharp focus\, as countries battle for scarce supplies of active ingredients\, medicines\, reagents and equipment to enable them to support the effort to combat the outbreak. \nJayne Hussey and Stephanie Caird from Mills & Reeve will cover: \n– How businesses can build supply chain resilience and agility \n– Offer some tips on how to get ahead of a crisis before it happens \n– How some businesses are adopting new ways of working to tackle some of the financial difficulties of disrupted supply chains \n– How to build really effective relationships with your key suppliers \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:  \n \nStephanie Caird\, Principal Associate\, commercial lawyer specialising in the life sciences sector\, Mills & Reeve\nStephanie is a lawyer specialising in the life sciences practice with experience in intellectual property\, data protection\, commercial contracting and regulatory work. She supports a wide range of clients in the pharma and biotech\, medical devices and diagnostic sectors.\nStephanie has also worked in-house for various life sciences organisations\, giving her a unique insight into her clients. She uses this experience to deliver pragmatic and commercial advice. A key focus of her work is supporting clients on strategic decisions influenced by the regulatory framework and contracts covering IP\, research collaboration and Brexit intra-group arrangements. \n\nJayne Hussey\, Partner\, commercial contracts specialist\, Mills & Reeve\nJayne is a commercial contracts specialist lawyer with a wealth of experience in advising businesses on complex supply chain arrangements\, including outsourcing contracts\, contract manufacturing arrangements and long term supply and purchasing arrangements. Jayne has international contracting expertise and has worked on a significant number of cross-border arrangements.\nJayne is highly regarded by clients for providing straightforward legal advice and support and ensuring that contractual arrangements are structured to deliver objectives. She is trusted by clients to assess proposed contracts in the context of a client’s appetite for risk and its governance framework.
URL:https://staging.medilinkmidlands.com/event/webinar-supply-chain-improving-resilience-and-agility-for-challenging-times/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/jayne-hussey.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201021T103000
DTEND;TZID=Europe/London:20201021T113000
DTSTAMP:20260422T030733
CREATED:20200820T075208Z
LAST-MODIFIED:20200820T075208Z
UID:18334-1603276200-1603279800@staging.medilinkmidlands.com
SUMMARY:Webinar: Introduction to NHS Market Access
DESCRIPTION:Join our two-part CPD accredited virtual workshop\, Introduction to NHS Market Access\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nCombined\, the two sessions will give innovators key insights into the complexities of the NHS and wider healthcare ecosystem as well as the support available to help you to introduce your health technology product or service into the NHS. \nPART 1 is a pre-recorded 45 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– The NHS Structure \n– Understanding pathways and cash flow \n– Getting your message right \n– What support you can expect from the AHSN \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Wednesday 21st October. \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \n  \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nSPEAKER PROFILE:  \nNicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands.
URL:https://staging.medilinkmidlands.com/event/webinar-introduction-to-nhs-market-access/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201022T103000
DTEND;TZID=Europe/London:20201022T120000
DTSTAMP:20260422T030733
CREATED:20200922T131336Z
LAST-MODIFIED:20200922T131336Z
UID:18375-1603362600-1603368000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: The Nottingham Recovery from COVID-19 Research Platform (NoRCoRP) - Developing New Approaches to Treatment
DESCRIPTION:Researchers in Nottingham have launched a new study platform for the next generation of COVID-19 clinical research: The Nottingham Recovery from COVID-19 Research Platform (NoRCoRP). \nThe platform will bring together projects examining the impacts and lasting effects of COVID-19\, translating findings from patients who are known to have contracted the virus into new approaches to treatment to support their recovery. To read about the background on all of the Nottingham Biomedical Research Centre’s COVID-19 research\, click here. \nAttend this webinar to find out about NoRCoRP plus: \n– Background to COVID-19: clinical presentations\, pathophysiology\n– Existing treatment strategies\n– Review of Nottingham portfolio of existing clinical trial and planned clinical studies in patients with COVID-19\n– PHOSP-COVID and NoRCoRP: follow up studies of patients who have had COVID-19\n– Opportunities for engagement with the NIHR Nottingham BRC for COVID related work \nDURATION: 1.5 hours \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profile: \n\nProfessor Ian Hall\, Director\, NIHR Nottingham Biomedical Research Centre \nProfessor Ian is the Director of the NIHR Nottingham\, Biomedical Research Centre. He is a chest physician based at NUH NHS Trust and the University of Nottingham\, and has a long track record of research into the mechanisms underlying the development of a range of lung diseases. He currently chairs the national BRC Director’s forum\, sits on NIHR Strategy Board\, and is a member of UK-CTAP.
URL:https://staging.medilinkmidlands.com/event/webinar-the-nottingham-recovery-from-covid-19-research-platform-norcorp-developing-new-approaches-to-treatment/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Ian-Hall-scaled.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201029T110000
DTEND;TZID=Europe/London:20201029T120000
DTSTAMP:20260422T030733
CREATED:20200824T083913Z
LAST-MODIFIED:20200824T083913Z
UID:18337-1603969200-1603972800@staging.medilinkmidlands.com
SUMMARY:Webinar: Food Supplements Special Interest Group (SIG)- CBD and the latest developments
DESCRIPTION:Join us online for our next Food Supplements Special Interest Group (SIG) to hear about how\, within the space of a couple of years\, CBD ingestibles have transitioned from a lightly regulated consumer product to potentially being classified as a narcotic and banned from the shelves of retail outlets in Europe. How did this happen and what’s the impact on the CBD industry? \nWe invite you to hear some of the facts around CBD\, providing clarity about its current status and the future challenges and opportunities for companies operating in this sector. All of this will be presented by our speakers\, Janet Worrell\, Head of Regulatory at JensonR+ and Greer Deal\, Director of Global Regulatory Services \nAs well as the opportunity to hear some facts about CBD you can take part in a question and answer session. \nDURATION: 1 Hour \nTO BOOK YOUR PLACE PLEASE CLICK HERE\nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nJanet Worrell\, Head of Regulatory\, JensonR+ \nJanet is an experienced regulatory affairs professional\, having supported a diverse portfolio of products\, for a number of companies across the East Midlands. Janet’s experience covers early concept development\, food supplements\, over the counter (OTC) medicines\, inhaled therapies and clinical trial applications. Janet enjoys collaborating with companies to develop their regulatory strategy to deliver commercial success. Janet is an independent board member of the East Midlands Academic Health Science Network supporting innovation within NHS. \n  \nGreer Deal\, Director\, Global Regulatory Services \nGreer has over 25 years’ experience in the life science sector and 13 years ago she co-founded Global Regulatory Services with her husband\, Bobby Deal. One of their first projects involved medicinal cannabis and since then the company has become increasingly involved in plant-derived products whether medicinal\, food or cosmetics. Since January 2019\, Global Regulatory Services has become known as the leading advisers to companies in the cannabis industry with particular expertise in navigating the EU Novel Foods Regulation.
URL:https://staging.medilinkmidlands.com/event/webinar-food-supplements-special-interest-group-sig-cbd-and-the-latest-developments/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Greer-Deal.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
END:VCALENDAR